Telavancin pharmacokinetics in patients with chronic kidney disease receiving haemodialysis.

Gharibian, Katherine N; Lewis, Susan J; Heung, Michael; Segal, Jonathan H; Salama, Noha N; Mueller, Bruce A

Gharibian, Katherine N; Lewis, Susan J; Heung, Michael; Segal, Jonathan H; Salama, Noha N; Mueller, Bruce A.

Affiliation

Gharibian KN; Amgen, Thousand Oaks, CA, USA.
Lewis SJ; Department of Pharmacy Practice, University of Findlay College of Pharmacy, Findlay, OH, USA.
Heung M; Department of Pharmacy, Mercy Health St. Anne Hospital, Toledo, OH, USA.
Segal JH; Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA.
Salama NN; Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA.
Mueller BA; Department of Pharmaceutics and Industrial Pharmacy, Cairo University Faculty of Pharmacy, Cairo, Egypt.

J Antimicrob Chemother ; 77(1): 174-180, 2021 12 24.

Article in En | MEDLINE | ID: mdl-34613416

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Renal Insufficiency, Chronic / Kidney Failure, Chronic Type of study: Observational_studies Limits: Humans Language: En Journal: J Antimicrob Chemother Year: 2021 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google